fenofibrate has been researched along with Ischemia in 9 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
Ischemia: A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We investigated the effect of fenofibrate (FEN) on induced testicular ischemia reperfusion (testicular (I-R)." | 7.88 | Upregulation of peroxisome proliferator activated receptor alpha by fenofibrate in induced testicular ischemia reperfusion. ( Refaie, MMM, 2018) |
| "These case reports aim to show that hyperfibrinogenemia is a risk factor for the progression and prognosis of peripheral arterial disease (PAD), in patients with and without diabetes mellitus type 2." | 7.88 | Hyperfibrinogenemia in Peripheral Arterial Disease: Coexistent and Independent Risk Factor (A Report of Two Cases and Review of Literature). ( Antova, E; Bosevska, G; Bosevski, M; Krstevski, G; Mitevska, I, 2018) |
| "Treatment with fenofibrate led to acceleration of revascularization of ischemic hindlimb relative to the contralatereal limb in wild-type (WT) mice, as measured by laser Doppler blood flow and capillary density analyses." | 5.36 | Fenofibrate promotes ischemia-induced revascularization through the adiponectin-dependent pathway. ( Kondo, M; Li, P; Maruyama, S; Murohara, T; Ohashi, K; Ouchi, N; Shibata, R, 2010) |
| " We investigated the effect of fenofibrate (FEN) on induced testicular ischemia reperfusion (testicular (I-R)." | 3.88 | Upregulation of peroxisome proliferator activated receptor alpha by fenofibrate in induced testicular ischemia reperfusion. ( Refaie, MMM, 2018) |
| "These case reports aim to show that hyperfibrinogenemia is a risk factor for the progression and prognosis of peripheral arterial disease (PAD), in patients with and without diabetes mellitus type 2." | 3.88 | Hyperfibrinogenemia in Peripheral Arterial Disease: Coexistent and Independent Risk Factor (A Report of Two Cases and Review of Literature). ( Antova, E; Bosevska, G; Bosevski, M; Krstevski, G; Mitevska, I, 2018) |
| " It seems that fenofibrate enhances angiogenesis in hind limb ischemia possibly through increasing of NO bioavailability and can be considered for treatment of diabetic peripheral vascular diseases in future human studies." | 1.38 | Role of fenofibrate in restoring angiogenesis in diabetic and control hind limb ischemic rats. ( Khazaei, M; Rashidi, B; Salehi, E, 2012) |
| "Treatment with fenofibrate led to acceleration of revascularization of ischemic hindlimb relative to the contralatereal limb in wild-type (WT) mice, as measured by laser Doppler blood flow and capillary density analyses." | 1.36 | Fenofibrate promotes ischemia-induced revascularization through the adiponectin-dependent pathway. ( Kondo, M; Li, P; Maruyama, S; Murohara, T; Ohashi, K; Ouchi, N; Shibata, R, 2010) |
| "Fenofibrate treatment significantly lowered serum triglyceride levels." | 1.35 | Fenofibrate enhances neovascularization in a murine ischemic hindlimb model. ( Fujihara, S; Harada, S; Hisatome, I; Kaetsu, Y; Katayama, A; Matsubara, K; Sugitani, M; Tanaka, K; Yamamoto, Y; Yoshida, A, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Jayasekera, CR | 1 |
| Barnhill, M | 1 |
| Chascsa, DM | 1 |
| Aqel, B | 1 |
| Carey, EJ | 1 |
| Vargas, HE | 1 |
| Refaie, MMM | 1 |
| Yuan, J | 1 |
| Tan, JTM | 1 |
| Rajamani, K | 1 |
| Solly, EL | 1 |
| King, EJ | 1 |
| Lecce, L | 1 |
| Simpson, PJL | 1 |
| Lam, YT | 1 |
| Jenkins, AJ | 1 |
| Bursill, CA | 1 |
| Keech, AC | 1 |
| Ng, MKC | 1 |
| Bosevski, M | 1 |
| Krstevski, G | 1 |
| Mitevska, I | 1 |
| Antova, E | 1 |
| Bosevska, G | 1 |
| Moran, E | 1 |
| Ding, L | 1 |
| Wang, Z | 1 |
| Cheng, R | 1 |
| Chen, Q | 1 |
| Moore, R | 1 |
| Takahashi, Y | 1 |
| Ma, JX | 1 |
| Katayama, A | 1 |
| Yamamoto, Y | 1 |
| Tanaka, K | 1 |
| Matsubara, K | 1 |
| Sugitani, M | 1 |
| Fujihara, S | 1 |
| Harada, S | 1 |
| Kaetsu, Y | 1 |
| Yoshida, A | 1 |
| Hisatome, I | 1 |
| Li, P | 1 |
| Shibata, R | 1 |
| Maruyama, S | 1 |
| Kondo, M | 1 |
| Ohashi, K | 1 |
| Ouchi, N | 1 |
| Murohara, T | 1 |
| Boshra, V | 1 |
| Moustafa, AM | 1 |
| Salehi, E | 1 |
| Khazaei, M | 1 |
| Rashidi, B | 1 |
9 other studies available for fenofibrate and Ischemia
| Article | Year |
|---|---|
Fenofibrate Improves Outcomes in Ischemic Cholangiopathy After Liver Transplantation.
Topics: Bile Duct Diseases; Fenofibrate; Humans; Ischemia; Liver Transplantation | 2023 |
Upregulation of peroxisome proliferator activated receptor alpha by fenofibrate in induced testicular ischemia reperfusion.
Topics: Animals; Apoptosis; Fenofibrate; Glutathione; Ischemia; Male; Malondialdehyde; NF-kappa B; Oxidative | 2018 |
Fenofibrate Rescues Diabetes-Related Impairment of Ischemia-Mediated Angiogenesis by PPARα-Independent Modulation of Thioredoxin-Interacting Protein.
Topics: Animals; Carrier Proteins; Diabetes Mellitus, Experimental; Fenofibrate; Glucose; Hindlimb; Ischemia | 2019 |
Hyperfibrinogenemia in Peripheral Arterial Disease: Coexistent and Independent Risk Factor (A Report of Two Cases and Review of Literature).
Topics: Amputation, Surgical; Anticholesteremic Agents; Atorvastatin; Diabetes Mellitus, Type 2; Fenofibrate | 2018 |
Protective and antioxidant effects of PPARα in the ischemic retina.
Topics: Animals; Animals, Newborn; Antioxidants; Apoptosis; Blotting, Western; Cells, Cultured; Disease Mode | 2014 |
Fenofibrate enhances neovascularization in a murine ischemic hindlimb model.
Topics: Animals; Disease Models, Animal; Endothelium, Vascular; Enzyme Inhibitors; Fenofibrate; Hindlimb; Hy | 2009 |
Fenofibrate promotes ischemia-induced revascularization through the adiponectin-dependent pathway.
Topics: Adenylate Kinase; Adiponectin; Animals; Cholesterol; Enzyme Inhibitors; Fenofibrate; Hindlimb; Immun | 2010 |
Effect of preischemic treatment with fenofibrate, a peroxisome proliferator-activated receptor-α ligand, on hepatic ischemia-reperfusion injury in rats.
Topics: Alanine Transaminase; Animals; Endothelium; Fenofibrate; Hepatic Stellate Cells; Hepatocytes; Ischem | 2011 |
Role of fenofibrate in restoring angiogenesis in diabetic and control hind limb ischemic rats.
Topics: Animals; Diabetic Angiopathies; Fenofibrate; Hindlimb; Hypolipidemic Agents; Ischemia; Male; Neovasc | 2012 |